Foreign Drug Presence Gaining Across China's Primary Healthcare Market
This article was originally published in PharmAsia News
Executive Summary
The extensive inclusion of foreign brand drugs in Shanghai's 2010 provincial essential drug list and China's upcoming price-cuts on brand drugs have sparked industry concerns that foreign branded drugs will further dominate the country's drug market by entering its primary healthcare segment